These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27577735)

  • 1. Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.
    de Mendonça LZ; Resende LA; Lanna MF; Aguiar-Soares RD; Roatt BM; Castro RA; Batista MA; Silveira-Lemos D; Gomes Jde A; Fujiwara RT; Rezende SA; Martins-Filho OA; Corrêa-Oliveira R; Dutra WO; Reis AB; Giunchetti RC
    Parasit Vectors; 2016 Aug; 9(1):472. PubMed ID: 27577735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and II Clinical Trial Comparing the LBSap, Leishmune
    Aguiar-Soares RDO; Roatt BM; Mathias FAS; Reis LES; Cardoso JMO; Brito RCF; Ker HG; Corrêa-Oliveira R; Giunchetti RC; Reis AB
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33212786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis.
    Fernandes CB; Junior JT; de Jesus C; Souza BM; Larangeira DF; Fraga DB; Tavares Veras PS; Barrouin-Melo SM
    Vaccine; 2014 Mar; 32(11):1287-95. PubMed ID: 24406392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population.
    Testasicca MC; dos Santos MS; Machado LM; Serufo AV; Doro D; Avelar D; Tibúrcio AM; Abrantes Cde F; Machado-Coelho GL; Grimaldi G; Gazzinelli RT; Fernandes AP
    Vet Parasitol; 2014 Aug; 204(3-4):169-76. PubMed ID: 24863572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.
    Roatt BM; Aguiar-Soares RD; Vitoriano-Souza J; Coura-Vital W; Braga SL; Corrêa-Oliveira R; Martins-Filho OA; Teixeira-Carvalho A; de Lana M; Figueiredo Gontijo N; Marques MJ; Giunchetti RC; Reis AB
    PLoS One; 2012; 7(11):e49780. PubMed ID: 23189161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field randomized trial to evaluate the efficacy of the Leish-Tec® vaccine against canine visceral leishmaniasis in an endemic area of Brazil.
    Regina-Silva S; Feres AM; França-Silva JC; Dias ES; Michalsky ÉM; de Andrade HM; Coelho EA; Ribeiro GM; Fernandes AP; Machado-Coelho GL
    Vaccine; 2016 Apr; 34(19):2233-9. PubMed ID: 26997002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis.
    Lopes Valentim Di Paschoale Ostolin T; Rodrigues Gusmão M; Augusto Siqueira Mathias F; Mirelle de Oliveira Cardoso J; Mendes Roatt B; Dian de Oliveira Aguiar-Soares R; Conceição Ruiz J; de Melo Resende D; Cristiane Fortes de Brito R; Barbosa Reis A
    Cell Immunol; 2022 Oct; 380():104592. PubMed ID: 36084402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
    Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
    Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells.
    Coler RN; Goto Y; Bogatzki L; Raman V; Reed SG
    Infect Immun; 2007 Sep; 75(9):4648-54. PubMed ID: 17606603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.
    Costa-Pereira C; Moreira ML; Soares RP; Marteleto BH; Ribeiro VM; França-Dias MH; Cardoso LM; Viana KF; Giunchetti RC; Martins-Filho OA; Araújo MS
    BMC Vet Res; 2015 Apr; 11():92. PubMed ID: 25880646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).
    Viana KF; Fiuza JA; Gannavaram S; Dey R; Selvapandiyan A; Bartholomeu DC; da Silveira-Lemos D; Bueno LL; Dutra WO; Fujiwara RT; Nakhasi HL; Giunchetti RC
    Parasit Vectors; 2016 Apr; 9():250. PubMed ID: 27136900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis.
    Resende LA; Roatt BM; Aguiar-Soares RD; Viana KF; Mendonça LZ; Lanna MF; Silveira-Lemos D; Corrêa-Oliveira R; Martins-Filho OA; Fujiwara RT; Carneiro CM; Reis AB; Giunchetti RC
    Vet Parasitol; 2013 Dec; 198(3-4):371-81. PubMed ID: 24129068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
    Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
    Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-gamma production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge.
    Marques-da-Silva EA; Coelho EA; Gomes DC; Vilela MC; Masioli CZ; Tavares CA; Fernandes AP; Afonso LC; Rezende SA
    Parasitol Res; 2005 Dec; 98(1):67-74. PubMed ID: 16261353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis.
    Martins VT; Lage DP; Duarte MC; Costa LE; Garde E; Rodrigues MR; Chávez-Fumagalli MA; Menezes-Souza D; Roatt BM; Tavares CA; Soto M; Coelho EA
    Acta Trop; 2016 Feb; 154():73-81. PubMed ID: 26593442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.
    Martins VT; Chávez-Fumagalli MA; Costa LE; Canavaci AM; Martins AM; Lage PS; Lage DP; Duarte MC; Valadares DG; Magalhães RD; Ribeiro TG; Nagem RA; Darocha WD; Régis WC; Soto M; Coelho EA; Fernandes AP; Tavares CA
    PLoS Negl Trop Dis; 2013; 7(3):e2148. PubMed ID: 23573301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pam3CSK4 adjuvant given intranasally boosts anti-Leishmania immunogenicity but not protective immune responses conferred by LaAg vaccine against visceral leishmaniasis.
    Salgado CL; Dias EL; Stringari LL; Covre LP; Dietze R; Lima Pereira FE; de Matos Guedes HL; Rossi-Bergmann B; Gomes DCO
    Microbes Infect; 2019; 21(7):328-335. PubMed ID: 30817996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.
    Rafati S; Zahedifard F; Azari MK; Taslimi Y; Taheri T
    Exp Parasitol; 2008 Mar; 118(3):393-401. PubMed ID: 18093586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis.
    Araújo MS; de Andrade RA; Sathler-Avelar R; Magalhães CP; Carvalho AT; Andrade MC; Campolina SS; Mello MN; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Rocha LM; Martins-Filho OA
    Vet Immunol Immunopathol; 2011 May; 141(1-2):64-75. PubMed ID: 21439654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.